1. 061 Rapid response with upadacitinib treatment in patients with rheumatoid arthritis and an inadequate response to csDMARDS or bDMARDS. (12th April 2019) Authors: FitzGerald, O; Rubbert-Roth, A; Chen, K; Meerwein, S; Enejosa, J; Shaw, T; Wells, A F Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA). Issue 5 (27th December 2010) Authors: Burmester, Gerd R; Feist, E; Kellner, H; Braun, J; Iking-Konert, C; Rubbert-Roth, A Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 5(2011) Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0217 Impact of rituximab in combination with leflunomide and rituximab retreatment with two different dosages on patient-reported outcomes: results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-STUDY). (15th June 2017) Authors: Köhm, M; Rossmanith, T; Dauth, S; Alten, R; Aringer, M; Backhaus, M; Burmester, G; Feist, E; Kellner, H; Krüger, K; Müller-Ladner, U; Rubbert-Roth, A; Tony, H-P; Wassenberg, S; Burkhardt, H; Behrens, F Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Issue 1 (11th October 2010) Authors: Tak, P P; Rigby, W F; Rubbert-Roth, A; Peterfy, C G; van Vollenhoven, R F; Stohl, W; Hessey, E; Chen, A; Tyrrell, H; Shaw, T M Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 1(2011) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. Issue 6 (17th January 2014) Authors: Emery, P; Gottenberg, J E; Rubbert-Roth, A; Sarzi-Puttini, P; Choquette, D; Taboada, V M Martínez; Barile-Fabris, L; Moots, R J; Ostor, A; Andrianakos, A; Gemmen, E; Mpofu, C; Chung, C; Gylvin, L Hinsch; Finckh, A Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 6(2015) Page Start: 979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0070 Baricitinib versus adalimumab in patients with active rheumatoid arthritis: analysis of patients achieving a moderate eular response at week 4. (15th June 2017) Authors: Kvien, TK; Riel, P van; Rubbert-Roth, A; Blanco, R; Liu-Leage, SS; Larsson, E; Lund, H; Lόpez-Romero, P; Zaremba-Pechmann, L; Emery, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012. (25th March 2013) Authors: Furst, Daniel E; Keystone, Edward Clark; So, Alexander K; Braun, Jürgen; Breedveld, Ferry C; Burmester, Gerd R; De Benedetti, Fabrizio; Dörner, Thomas; Emery, Paul; Fleischmann, Roy; Gibofsky, Allan; Kalden, J R; Kavanaugh, Arthur; Kirkham, Bruce; Mease, Philip; Rubbert-Roth, A; Sieper, Joachim; ... Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 2(2013) Page Start: ii2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗